Surveillance for early detection of aggressive parathyroid disease: Carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation

Journal of Bone and Mineral Research

Volumn 21, Issue 10, 2006, Pages 1666-1671

  Kelly, Thomas G ^a   Shattuck, Trisha M ^b   Reyes Mugica, Miguel ^a   Stewart, Andrew F ^c   Simonds, William F ^d   Udelsman, Robert ^a   Arnold, Andrew ^b   Carpenter, Thomas O ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

CDC73; Familial parathyroid disorders; Genetics; Hyperparathyroidism; Parathyroid carcinoma; Parathyroid tumorigenesis

Indexed keywords

CELL DNA;

ADOLESCENT; ARTICLE; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EARLY DIAGNOSIS; EXON; FAMILIAL DISEASE; FAMILIAL ISOLATED HYPERPARATHYROIDISM; FAMILY HISTORY; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC SCREENING; GERM LINE; HISTOPATHOLOGY; HRPT2 GENE; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; MALE; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; PARATHYROID TUMOR; PRIMARY HYPERPARATHYROIDISM; RARE DISEASE; SYNDROME; TUMOR SUPPRESSOR GENE;

ADENOMA; BASE SEQUENCE; CARCINOMA; CHILD; GENETIC SCREENING; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MOLECULAR SEQUENCE DATA; PARATHYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 33749257125     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.060702     Document Type: Article

References (35)

1. Adami S, Marocci C, Gatti D 2002 Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 17:S2;N18-N23.
2. Marx SJ, Simonds WF, Agarwal SK, Burns AL, Weinstein LS, Cochran C, Skarulis MC, Spiegel AM, Libutti SK, Alexander HR Jr, Chen CC, Chang R, Chandrasekharappa SC, Collins FS 2002 Hyperparathyroidism in hereditary syndromes: Special expressions and special managements. J Bone Miner Res 17:S2;N37-N43.
3. Jackson CE, Norum RA, Boyd SB, Talpos GB, Wilson SD, Taggart RT, Mallette LE 1990 Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: A clinically and genetically distinct syndrome. Surgery 108:1006-1012.
4. Wassif WS, Farnebo F, Teh BT, Moniz CF, Li FY, Harrison JD, Peters TJ, Larsson C, Harris P 1999 Genetic studies of a family with hereditary hyperparathyroidism-jaw tumor syndrome. Clin Endocrinol (Oxf) 50:191-196.
5. Kennet S, Pollick H 1971 Jaw lesions in familial hyperparathyroidism. Oral Surg Oral Med Oral Pathol 31:502-510.
6. Eversole LR, Leider AS, Nelson K 1985 Ossifying fibroma: A clinicopathologic study of 64 cases. Oral Surg Oral Med Oral Pathol 60:505-511.
7. Szabo J, Heath B, Hill VM, Jackson CE, Zarbo RJ, Mallette LE, Chew SL, Besser GM, Thakker RV, Huff V, Leppert MF, Heath H III 1995 Hereditary hyperparathyroidism-jaw tumor syndrome: The endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet 56:944-950.
8. Teh BT, Farnebo F, Kristoffersson U, Sundelin B, Cardinal J, Axelson R, Yap A, Epstein M, Heath H III, Cameron D, Larsson C 1996 Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: Linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J Clin Endocrinol Metab 81:4204-4211.
9. Haven CJ, Wong FK, van Dam EW, van der Juijt R, van Asperen C, Jansen J, Rosenberg C, de Wit M, Roijers J, Hoppener J, Lips CJ, Larsson C, Teh BT, Morreau H 2000 A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 85:1449-1454.
10. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Hoog A, Heath H III, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR 2002 HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32:676-680.
11. Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, Shanmugam KS, Copeland TD, Guszczynski T, Resau JH, Meyerson M 2005 The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol 25:612-620.
12. Woodard GE, Lin L, Zhang JH, Agarwal SK, Marx SJ, Simonds WF 2005 Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression. Oncogene 24:1272-1276.
13. Goldman L 1936 Hyperparathyroidism in siblings. Ann Surg 104:971-981.
14. Goldsmith RE, Sizemore GW, Chen IW, Zalme E, Altemeier WA 1976 Familial hyperparathyroidism: Description of a large kindred and a review of the literature. Ann Intern Med 84:36-43.
15. Teh BT, Farnebo F, Twigg S, Hoog A, Kytola S, Korpi-Hyovalti E, Wong FK, Nordenstrom J, Grimelius L, Sandelin K, Robinson B, Farnebo LO, Larsson C 1998 Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-32 in a subset of families. J Clin Endocrinol Metab 83:2114-2120.
16. Cetani F, Pardi E, Giovannetti A, Vignali E, Borsari S, Golia F, Cianferotti L, Viacava P, Miccoli P, Gasperi M, Pinchera A, Marcocci C 2002 Genetic analysis of the MEN1 gene and HRPT2 locus in two Italian kindreds with familial isolated hyperparathyroidism. Clin Endocrinol (Oxf) 56:457-464.
17. Villablanca A, Calender A, Forsberg L, Hoog A, Cheng JD, Petillo D, Bauters C, Kahnoski K, Ebeling T, Salmela P, Richardson AL, Delbridge L, Meyrier A, Proye C, Carpten JD, Teh BT, Robinson BG, Larsson C 2004 Germline and de novo mutations in the HRPT2 tumor supressor gene in familial isolated hyperparathyroidism. J Med Genet 41:E32.
18. Simonds WF, Robbins CM, Agarwal SK, Hendy GN, Carpten JD, Marx SJ 2004 Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 89:96-102.
19. Marx SJ 2000 Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 343:1863-1875.
20. Shattuck TM, Valimaki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, Farnebo LO, Larsson C, Arnold A 2003 Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722-1729.
21. Cetani F, Pardi E, Borsari S, Viacava P, Dipollina G, Cianferotti L, Ambrogini E, Gazzerro E, Colussi G, Berti P, Miccoli P, Pinchera A, Marcocci C 2004 Genetic analysis of the HRPT2 gene in primary hyperparathyroidism: Germline and somatic mutations in alterations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 89:5583-5591.
22. Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Hammje K, Dralle H, Hoang-Vu C, Gimm O, Marsh DJ, Morreau H, Teh BT 2003 HRPT2 mutations are associated with malignancy in sporadic parathyroid carcinomas. J Med Genet 40:657-663.
23. Farnebo F, Auer G, Farnebo LO, Teh BT, Twigg S, Aspenblad U, Thompson NW, Grimelius L, Larsson C, Sandelin K 1999 Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease. World J Surg 23:68-74.
24. Solcia E, Kloppel G, Sobin LH 2000 Tumours of the parathyroid glands. In: Solcia E (ed.) World Health Organization International Histological Classification of Tumours. Histological Typing of Endocrine Tumours, 2nd ed. Springer-Verlag, New York, NY, USA, pp. 48-55.
25. Apel RL, Asa SL 2002 The parathyroid glands. In: LiVolsi VA, Asa SL (eds.) Endocrine Pathology. Churchill Livingston, Philadelphia, PA, USA, pp. 124-128.
26. Bondeson L, Sandelin K, Grimelius L 1993 Histopathological variables and DNA cytometry in parathyroid carcinoma. Am J Surg Pathol 17:820-829.
27. Roth SI 1962 Pathology of the parathyroids in hyperparathyroidism. Arch Pathol 73:495-510.
28. Schantz A, Castleman B 1973 Parathyroid carcinoma: A study of 70 cases. Cancer 31:600-605.
29. Vetto JT, Brennan MF, Woodruf J, Burt M 1993 Parathyroid carcinoma: Diagnosis and clinical history. Surgery 114:882-892.
30. Sandelin K, Thompson NW, Bondeson L 1991 Metastatic parathyroid carcinoma: Dilemma in the management. Surgery 110:978-986.
31. Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO 1992 Prognostic factors in parathyroid cancer: A review of 95 cases. World J Surg 16:724-731.
32. Anderson BJ, Samaan NA, Vassilopoulou-Sellin R, Ordonez NG, Hickey RC 1983 Parathyroid carcinomas: Features and difficulties in diagnosis and management. Surgery 94:906-915.
33. de Papp AE, Kinder B 1994 LiVolsi V, Gupta SM, Stewart AF. Parathyroid carcinoma arising from parathyroid hyperplasia: Autoinfarction following intravenous treatment with pamidronate. Am J Med 97:399-400.
34. Carpenter TO, Mitnick MA, Ellison A, Smith C, Insogna KL 1994 Nocturnal hyperparathyroidism: A frequent feature of X-linked hypophosphatemia. J Clin Endocrinol Metab 78:1378-1383.
35. Carling T, Udelsman R 2005 Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med 257:27-37.